Introduction
One out of six men will be diagnosed with prostate cancer during their lifetime. One out of thirty-six patients will not survive the disease. Death from prostate cancer results when cancer cells become metastatic after invading lymph nodes and blood vessels and migrate to the bone (1) . The mainstay of treatment for metastatic prostate cancer has been androgen ablation conferring improved survival to patients with advanced disease (2) . The apoptotic response to androgen ablation is the underlying mechanism driving tumor regression and therapeutic benefit in prostate cancer patients (3) . The majority of prostate tumors recur however emerging as castration-resistant causing mortality, due to distinct molecular and genetic changes reactivating the androgen receptor (AR) signaling and conferring resistance to androgen-deprivation induced apoptosis (4, 5) . Dynamic interactions between cancer cells, and the tumor microenvironment consisting of the reactive stroma (6, 7) , inflammatory cells, angiogenic vessels, fibroblasts and components of the ECM, dictate tumor invasion (8) (9) (10) and confer androgen-insensitivity in metastatic prostate cancer (11) .
Cancer metastasis is regulated by signaling contributions from the microenvironment promoting cell detachment from the primary tumor and extracellular matrix (ECM) (12, 13) , acquisition of epithelial-mesenchymal transition (EMT) phenotype and invasion into the surrounding tissue (14) , resistance to anoikis (15, 16) , and migration via a chemoattractive path to a metastatic site (17) (18) . A distinct molecular program regulates the adhesion, EMT, migratory and invasive properties of disseminating tumor cells, all processes impacted by the dynamics of the cytoskeleton (16, 19) . The cellular cytoskeleton consists of a dynamic net of actin filaments rapid polymerization and depolymerization of which, allows the cell to move toward extracellular stimuli (20) (21) (22) . The ADF/cofilin protein is a small (19 kDa (23, 24) . CFL binding causes a reduction in actin filament rotation allowing a free barbed end for the addition of new actin monomers (25, 26) . CFL phosphorylation on Ser3 by LIMK-2 inhibits its binding to G actin (monomeric actin) and Factin (filamentous actin) and severing of the actin filament in mammalian cells (19, 27) . The Rho-associated, coiled-coil containing protein kinase 1 (ROCK1), is responsible for LIMK-2 phosphorylation and activation (28, 29) . Actin polymerization regulated by CFL dephosphorylation/activation is a convergence point in the intracellular network through which extracellular stimuli impact actin cytoskeleton, invasion and apoptosis (21, 25, 30) .
Transforming growth factor-β (TGF-β) functionally contributes to tumor progression to metastasis via its critical control of apoptosis and proliferation in the early stages of tumorigenesis, and its ability to promote angiogenesis, migration, invasion and immunity in late stages of metastastic spread (31) (32) (33) . TGF-β signaling is propagated via (serine threonine kinases) transmembrane receptors (TβRI and TβRII), activation of which leads to downstream regulation of SMADs intracellular effectors in target cells, including prostate cancer (34) (35) (36) . The mechanism via which TGF-β is functionally converted from a suppressor of pre-malignant cells to a tumor progression supporter of metastasis is unknown (37) .
Elucidating the contribution of the actin cytoskeleton to this critical phenomenon in prostate tumorigenesis will enable a novel platform for defining predictive markers of metastasis, as well as potential therapeutic targets. CFL was previously identified in this laboratory as a Smad-independent intracellular effector of TGF-β signaling in prostate cancer cells (38) . This study investigated the role of active CFL in directing TGF-β to elicite metastatic responses in prostate cancer. We generated a series of cofilin phosphorylated/dephosphorylation mutants 
Materials and Methods

Cell Culture and Transfections
The human prostate cancer cell lines PC-3 and LNCaP, was obtained from the Primary cultures of human prostate fibroblasts were passaged in the user's laboratory not more than three times prior to use tor the co-culture experiments. The S3A and T25A cofilin mutant prostate cancer cell lines were generated by site directed mutagenesis in PC-3 cells.
Briefly, a point mutation targeting the Ser 3 phosphorylation or the Threonine 25 sites were induced by PCR. To mimic a dephosphorylated (constitutively active) form of cofilin (S3ACFL), a substitution of a Serine on position 3 to Alanine was generated. WT, S3ACFL
and T25ACFL mutant forms of cofilin were introduced into PC-3 cells via stable transfection. S3D cofilin mutation, mimicking the constitutive phosphorylated (inactive) 
Statistical Analysis
Statistical analyses are performed with GraphPad Prism 5 for Windows (GraphPad Software, San Diego, CA). Data are presented as means +SEM. Numerical values are the mean of three independent experiments. Statistical evaluation of the data is performed using the Student t test and Two-way analysis of variance for multiple comparisons. Significant difference is defined at a P value < 0.05.
Results
Cofilin Activity Directs TGF-β Mediated Actin Severing in Prostate Cancer Cells
Recent work on the actin cytoskeleton dynamics in prostate cancer metastasis led to the characterization of significant protein interactions (in the tumor microenvironment) targeting of which potentially impairs metastastic progression (39) (40) (41) (42) . The present study identified the functional contribution of CFL to the process of prostate cancer metastasis in the context of processing signals from the microenvironment. Previously we identified CFL as a Smad independent effector of TGF-β mediated apoptosis signaling in prostate cancer cells by virtue of its cytosolic release (38) . In order to assess the effect of exogenous TFG-β in CFL phosphorylation status and activity consitutively active (dephosphorylated) forms of CFL were generated in PC- Author Manuscript Published OnlineFirst on February 7, 2014; DOI: 10.1158/0008-5472.CAN- revealed that the S3ACFL mutation specifically conferring CFL dephosphorylation, promotes its association with actin (enhancing filament severing), while the T25ACFL mutation, (impairing Threonine phosphorylation) had no effect on the association of p-cofilin with actin (Fig. 1) . Moreover, the presence of MEK inhibitor (PD98059) abrogated the TGF-β mediated association between p-Erk and cofilin (Fig. 1) . The mutational activation/cofilin dephosphorylation status (S3ACFL or T25ACFL), or silencing CFL expression (shCFL) had no significant consequences on prostate cancer cell viability ( Supplementary Fig. S1A ).
TGF-β treatment significantly increased the WTCFL PC-3 cell invasion (inactive cofilin), while loss of cofilin abolished prostate cancer cell invasion ( Supplementary Fig. S1B ). PC-3 cells harboring the constitutive dephosphorylated (active) cofilin (S3ACFL) had a modestly enhanced invasive response to TGF-β ( Supplementary Fig.S1B ). The S3ACFL mutation, as expected, abrogated its phosphorylation by LIMK-2, without affecting total cofilin expression (Fig. 2A) ; there was a compensatory upregulation of LIMK-2 levels in the S3ACFL PC-3 cells compared to WTCFL (Fig. 2A) . Figure 2B (Fig. 2, panels C and D) . This temporal phosphorylation of CFL in response to TGF-β was also detected in another human prostate cancer cell line that has restored sensitivity to the cytokine, LNCaP TβRII (Supplementary Fig.S2 ). 
Active Cofilin Dictates Prostate Cancer Cell Migration and Invasion Responses to TGF-β (via Reactive Stroma)
The effect of TGF-β on prostate cancer cell migration was analyzed in two different human prostate cancer cell lines with normal CFL function, LNCaP TβRII and WTCFL PC-3 cells; Treatment with TGF-β (24hrs) led to a significant decrease in prostate cancer cell migration for both cell lines (Fig. 3, panels A and B) . Functional blocking of TGF-β by the neutralizing antibody against the cytokine, restored migration capacity to control levels in both cell lines LNCaP TβRII and WTCFL PC-3 (Fig. 3) . To determine the effect of a mutation in CFL phosphorylation site on prostate cancer cell migration, we comparatively assessed the migration ability of S3ACFL mutants mimicking the constitutively active form of cofilin and as a functional control, S3DCFL mimicks the constitutively inactive form. The S3A cofilin mutation resulted in a significant increase in PC-3 cell migration (Fig. 3B) , while the induced-loss of TGF-β (by neutralizing antibody), further increased S3ACFL cell migration (Fig. 3B) . In contrast, a significant decrease in both cell migration ( Supplementary   Fig.S3A ) and cell adhesion to ECM (Supplementary Fig.S3B ) was observed for the inactive S3DCFL cells compared to the S3ACFL cells. The impact of S3ACFL mutation on prostate cancer cell invasion was interrogated in the context of tumor microenvironment. The quantitative data from the invasion assay indicate no significant difference in the invasion potential of S3ACFL cells compared to WTCFL PC-3 cells (Fig. 4A) . The increase in invading cell number in response to exogenous TGF-β was abrogated by the presence of the neutralizing antibody against TGF-β, in both WTCFL and S3ACFL cells (p<0.05).
The reactive stroma contributes to prostate cancer progression through the cancerassociated fibroblasts that facilitate metastasis (39, 40) . To assess whether the effect of CFL 
14 on prostate tumor cell invasion is TGF-β-dependent as mediated from surrounding cancer associated fibroblasts ( Supplementary Fig. S4 ), prostate cancer cell invasion was evaluated in in vitro co-cultures. Fluorescent labeled PC-3 prostate cancer epithelial cells (red) were cocultured with labeled human prostate cancer associated fibroblasts (green) in the upper chamber of a matrigel pre-coated transwell insert for 24hrs (Fig. 4B) . Only prostate tumor epithelial cells invaded the matrigel. There was no significant difference in cell invasion between WTCFL and S3ACFL cell lines (but there was a decrease in the S3D mutant cells).
In the presence of human prostate cancer associated fibroblasts (CAFs) however, there was a significant increase in the number of tumor epithelial cells invading, for both WTCFL PC-3 and LNCaPTβRII cells (Fig. 4 , panels C and D, respectively). The S3D CFL mutation (phosphorylation) had no effect on prostate cancer cell invasion regardless of TGF-β status (Fig. 4C) . Simultaneous exposure to the TGF-β neutralizing antibody yielded an additional significant increase in the S3ACFL cell invasion potential (p< 0.004). In contrast in two different prostate cancer cell lines with normal cofilin function WTCFL PC-3 cells and LNCaPTβRII cells, we observed the expected reduction in invasion. These data demonstrate that only active cofilin was able to functionally direct TGF-β signaling (secreted by the CAFs in the microenvironment) in promoting invasive behavior.
Cofilin Mediates Prostate Cancer Cell Adhesion via Cytoskeletal Remodeling
Cell adhesion is directly dependent on cofilin activity and cytoskeletal actin since depolimeryzation and polymerization of new actin filaments is required for filopodia formation (41) . We subsequently investigated the effect of S3A mutation on prostate cancer cell adhesion to fibronectin (ECM) and filopodia formation. S3ACFL cells exhibited a significantly increased cell adhesion to fibronectin compared to control WTCFL cells (Fig.   5A ). This correlated with cytoskeletal remodeling as indicated by fluorescence staining of Factin and formation of filopodia (Fig. 5B) . Confocal microscopy revealed an increased number of filopodia protrusions in S3ACFL PC-3 (arrows) compared to WTCFL PC-3 cells (Fig. 5B) . High cofilin expression was detected at cell membrane regions populated by filopodia. Treatment with TGF-β led to a significant decrease in S3ACFL cell adhesion (Fig.   5A ), and a reduction in filopodia protrusions (Fig. 5B) . To determine whether this CFL colocalization with filopodia is dependent on endogenously derived TGF-β from the surrounding prostate cancer associated fibrobalsts (reactive stroma), we used conofcal microscopy to profile the CFL/rhodamine phalloidin co-colocalization, in S3ACFL prostate epithelial cancer cells co-cultured with human CAFs. As shown on Figure 5C , cofilin (green) colocalizates with filopodia protrusions (arrows) and loss of TGF-β resulted in increased actin/cofilin colocalization (yellow) with filopodia protrusions in S3ACFL cells in this reactive stroma-tumor microenvironment.
Active Cofilin Enhances Prostate Cancer Metastasis In Vivo
In the experimental metastasis assay, prostate cancer cells harboring the S3ACFL mutation exhibited an increased metastatic ability in vivo, compared to WTCFL PC-3 prostate cancer cells, as determined by the higher number of lung metastases (Fig. 6A ).
Sustained exposure of prostate cancer cells with active cofilin, to TGF-β abundantly secreted in vivo, may promote their invasive properties towards metastasis (Fig. 6B) on (Fig. 7A) . Quantitative analysis indicated a significant increase in CFL levels in metastatic tumors (28-wks) compared to early stage tumors and normal prostate (16-wks WT) (Fig. 7, panels A and B) . Immunohistochemical profiling of CFL in human prostate tissue specimens from a patient cohort with localized and metastatic disease to the lymph nodes and quantitative assessment of the staining ( Supplementary Fig.S5 ), revealed a striking increase in CFL expression in metastasis compared to primary cancer in the same patient (Fig. 7, panels C and D) . Characteristic images of CFL immunoreactivity in serial sections of primary prostate tumors and metastasis are shown on Figure 7 , panels C and D. CFL levels were significantly increased in metastasis compared to primary prostate cancer (p=0.006), while there were no significant differences in the expression of p-CFL or palladin proteins between primary and metastatic prostate cancer (Fig. 7E) . 
remodeling critical cell-ECM adhesion sites and metastatic dissemination in vivo. The protein-protein interactions coordinating these events are being pursued.
Our data frame a microenvironment landscape in which CFL activation (due to mutations on phosphorylation site), promotes prostate cancer cell migration and metastatic spread by increasing severing activity and actin interactions. Cancer associated fibroblasts substantially enhance the invasive properties of prostate cancer cells with constitutively active cofilin, possibly via a sustained release of TGF-β. This evidence provides a proof-ofprinciple on a direct pro-invasive crosstalk between surrounding cancer associated fibroblasts and prostate cancer cells with TGF-ß functioning as a tumor suppressor by activating the RhoA/ROCK1 signaling, leading to phosphorylation and activation of LIMK-2. This impairs cofilin severing activity, cytoskeletal reorganization and formation of filopodia, decreasing tumor cell migration (shown schematically on Fig. 6B ). During prostate cancer progression active cofilin directs an action switching for TGF-ß to elicit metastatic responses, by enabling actin cytoskeleton remodeling and invasive tumor cell behavior. Taken together these results provide a first insight into the role of TGF-β to impair prostate cancer growth in the early stages by putting the "breaks" on cofilin activity (via phosphorylation) and consequently compromising actin severing action. During the late stages of tumor progression, a mutation conferring constitutive activation of cofilin, enables the escape to TGF-β-regulated phosphorylation by LIMK-2. In sharp contrast to an expected "action independence" from this cytokine, sustained exposure of prostate cancer cells, now harboring active cofilin (S3CFL mutation), to TGF-β secreted by the stroma microenvironment, promotes their migratory and invasive properties towards metastasis (Fig. 6B) 
